Mifepristone

The NWHN is Disappointed in the 5th Circuit Court’s Decision Regarding Mifepristone

By NWHN Staff | Aug 16, 2023 | Comments Off on The NWHN is Disappointed in the 5th Circuit Court’s Decision Regarding Mifepristone

Although the 5th Circuit Court’s decision does not go as far as anti-abortion advocates might have hoped, it is still a grave threat to abortion access.

Everything You Need to Know About Mifepristone, Medication Abortion Access, and the Case Working Its Way Through the Courts Right Now

By Kristen Batstone | Apr 26, 2023 | Comments Off on Everything You Need to Know About Mifepristone, Medication Abortion Access, and the Case Working Its Way Through the Courts Right Now

~~~

A Statement on the Supreme Court’s Mifepristone Decision

By NWHN Staff | Apr 21, 2023 | Comments Off on A Statement on the Supreme Court’s Mifepristone Decision

The National Women’s Health Network applauds the Supreme Court for its decision to block the lower court’s ruling against Mifepristone, one of two medication abortion drugs, until the end of the legal proceedings.

The National Women’s Health Network’s Statement on the Nationwide Ban of Mifepristone

By NWHN Staff | Apr 7, 2023 | Comments Off on The National Women’s Health Network’s Statement on the Nationwide Ban of Mifepristone

We are gravely concerned about this new nationwide barrier to abortion access.

The FDA tried to ignore you, so we took your names to the FDA!

By Sarah Christopherson | Sep 30, 2020 | Comments Off on The FDA tried to ignore you, so we took your names to the FDA!

On September 28 — the 20th anniversary of FDA’s approval of the abortion pill — we held a socially distanced protest in front of FDA headquarters and delivered the names of all 12,000+ of our petition signers.

It’s Time to #MailTheAbortionPill

By Sarah Christopherson | Jul 1, 2020 | Comments Off on It’s Time to #MailTheAbortionPill

Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.

The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them

By Sarah Christopherson | May 8, 2020 | Comments Off on The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them

The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.

The FDA Must Permit Pregnant People to Get the Abortion Pill Where They Have the Abortion — at Home!

By Evita Almassi | Apr 6, 2020 | Comments Off on The FDA Must Permit Pregnant People to Get the Abortion Pill Where They Have the Abortion — at Home!

FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org 

NWHN Statement in Response to the FDA’s Action Against Aid Access

By Cindy Pearson | Mar 12, 2019 | Comments Off on NWHN Statement in Response to the FDA’s Action Against Aid Access

FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org or (202) 682-6240

How Medication Abortion Changes the Narrative of Self-Managed Abortions

By Tessa Ruff | Jan 29, 2019 | Comments Off on How Medication Abortion Changes the Narrative of Self-Managed Abortions

Writing for Jezebel last year, Dr. Meera Shah described just a few of the many reasons why pregnant people might prefer self-managed (or self-induced) abortion to an abortion performed in a clinic.